Decrease in uptake of SARS-CoV-2 vaccine in patients with inflammatory bowel disease on intravenous biological therapy

Lancet Gastroenterol Hepatol. 2022 Nov;7(11):984-985. doi: 10.1016/S2468-1253(22)00302-8. Epub 2022 Sep 22.
No abstract available

Publication types

  • Letter

MeSH terms

  • Biological Therapy
  • COVID-19 Vaccines
  • COVID-19* / prevention & control
  • Chronic Disease
  • Humans
  • Inflammatory Bowel Diseases* / drug therapy
  • SARS-CoV-2

Substances

  • COVID-19 Vaccines